Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Celerion Gains Import License | Contract Pharma

What are you searching for?

Sign in
Breaking News

Celerion Gains Import License

Allows for import of Investigational Medicinal Products (IMPs) at Belfast facility

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Celerion’s clinical research operations in Belfast, Northern Ireland, have received authorization from the Medicines and Healthcare product Regulatory Agency (MHRA) to have importation of IMPs added to its manufacturing (MIA(IMP)) license. The license eliminates the need for a third party vendor to import IMPs on behalf of Celerion. According to the company, this saves time, costs, and initiates direct communication earlier with clients to expedite early-stage clinical studies.

“The addition of the import license was based on client demand and continues to demonstrate the high quality work and experience at Celerion,” said Phil Bach, vice president of Global Clinical Research at Celerion. “This import license underpins Celerion’s commitment to a global clinical strategy and reduces the lead time from study concept to first dosing. Clients also benefit from reduced costs by eliminating third party storage and transport prior to certification of the product.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics